Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice
Authors:
- 1 November 2014
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 261, 610-619
Abstract
No abstract availableKeywords
Funding Information
- New York State Office for People with Developmental Disabilities
- Alzheimer's Association (IIRG-10-170405, IIRG-10-173154)
This publication has 52 references indexed in Scilit:
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJournal of Clinical Investigation, 2012
- Mechanisms Underlying Insulin Deficiency-Induced Acceleration of β-Amyloidosis in a Mouse Model of Alzheimer's DiseasePLOS ONE, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Insulin-resistant brain state: The culprit in sporadic Alzheimer's disease?Ageing Research Reviews, 2011
- Brain glucose transporters, O‐GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer’s diseaseJournal of Neurochemistry, 2009
- Insulin Receptor Dysfunction Impairs Cellular Clearance of Neurotoxic Oligomeric AβJournal of Biological Chemistry, 2009
- Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's diseaseBrain, 2009
- Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic miceBMC Neuroscience, 2008
- Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer diseaseFEBS Letters, 2008
- Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD miceNeurobiology of Disease, 2007